Angel Eye Health is a technology company.
Angel Eye Health has raised $11.0M across 1 funding round.
Angel Eye Health has raised $11.0M in total across 1 funding round.
# AngelEye Health: High-Level Overview
AngelEye Health is a healthcare technology company that provides virtual engagement solutions for neonatal and pediatric intensive care units (NICUs and PICUs). The company builds a HIPAA-compliant platform centered on bedside camera systems that enable real-time video streaming, secure messaging, and clinical data integration, allowing parents and care teams to maintain continuous connection and engagement throughout a child's critical care stay[1][2].
The company serves over 300 hospitals nationwide with an installed base of nearly 10,000 bedside cameras[2]. AngelEye addresses a fundamental problem in critical care: the physical and informational barriers that separate families from their hospitalized children and prevent seamless communication between care teams and parents. By removing these barriers, the platform measurably reduces length of stay, minimizes clinical errors, and optimizes resource allocation while improving patient satisfaction and family peace of mind[2][4].
# Origin Story
AngelEye Health was founded in 2013 and is headquartered in Nashville, Tennessee[1]. The company emerged from recognizing a critical gap in neonatal care delivery—the emotional and logistical challenges families face when their infants require intensive care, combined with the operational inefficiencies that arise from siloed communication between providers and families. The founding vision centered on leveraging technology to create family-centered care models that benefit both patients and clinical workflows[4].
The company has demonstrated significant traction, progressing to a Series B funding round and achieving recognition as a 2025 Inc. Power Partner Award winner, validating its market fit and operational excellence[1][3].
# Core Differentiators
# Role in the Broader Tech Landscape
AngelEye Health operates at the intersection of two powerful healthcare trends: the shift toward virtual care and remote monitoring and the growing emphasis on family-centered care models in critical care settings. The company is riding the broader digitization of healthcare, where hospitals increasingly recognize that technology can simultaneously improve clinical outcomes, reduce operational costs, and enhance patient and family satisfaction[4].
The timing is particularly favorable given rising malpractice costs and patient demands for better communication and accountability—factors that create strong economic incentives for hospitals to adopt solutions that improve engagement and reduce adverse events[4]. By positioning itself as the comprehensive platform for NICU and PICU engagement rather than a single-purpose tool, AngelEye influences how hospitals think about the role of technology in family-centered care delivery.
# Quick Take & Future Outlook
AngelEye Health is well-positioned for continued growth as hospitals increasingly recognize that virtual engagement solutions are not luxuries but operational necessities. The company's 2025 roadmap—which emphasizes AI-driven features and enhanced clinical analytics—suggests it is evolving from a communication platform into a clinical decision-support tool[2]. This expansion into predictive analytics and risk identification could significantly broaden its value proposition and market opportunity.
The key question for AngelEye's trajectory is whether it can successfully execute its AI integration strategy while maintaining the ease of use and reliability that have driven adoption across 300+ hospitals. Success here would position the company not just as a family engagement tool, but as a foundational platform for optimizing NICU operations in an era where data-driven, family-integrated care is becoming the standard of practice.
Angel Eye Health has raised $11.0M in total across 1 funding round.
Angel Eye Health's investors include Mountain Group Partners.
Angel Eye Health has raised $11.0M across 1 funding round. Most recently, it raised $11.0M Series B in November 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2022 | $11.0M Series B | Mountain Group Partners |